Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.18% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13376
Cardiff Oncology
CRDF
$80.1M
| $11.6K | ﹤0.01% |
7,007
+1,291
| +23% | +$2.22K |
|
13377
Laird Superfood
LSF
$48.1M
| $11.6K | ﹤0.01% |
14,259
-3,381
| -19% | -$3.56K |
|
13378
CALL
Vanda Pharmaceuticals
VNDA
$304M
| $11.5K | ﹤0.01% |
1,700
-4,400
| -72% | -$30.9K |
|
13379
PUT
AvePoint
AVPT
$2.75B
| $11.5K | ﹤0.01% |
2,800
-15,100
| -84% | -$68.1K |
|
|
GHL
13380
PUT
DELISTED
Greenhill & Co., Inc.
GHL
| $11.5K | ﹤0.01% |
1,300
-1,800
| -58% | -$20.5K |
|
13381
PUT
CNB Financial Corp
CCNE
$1.02B
| $11.5K | ﹤0.01% |
600
+200
| +50% | +$4.57K |
|
13382
PUT
Ampco-Pittsburgh
AP
$176M
| $11.5K | ﹤0.01% |
4,700
+1,100
| +31% | +$3.14K |
|
|
RDNW
13383
PUT
RideNow Group
RDNW
$248M
| $11.5K | ﹤0.01% |
1,900
+600
| +46% | +$4.89K |
|
13384
CALL
Instil Bio
TIL
$50.3M
| $11.5K | ﹤0.01% |
870
+660
| +314% | +$9.75K |
|
13385
PUT
CytomX Therapeutics
CTMX
$750M
| $11.5K | ﹤0.01% |
7,600
+3,000
| +65% | +$6.78K |
|
13386
Ascent Solar Technologies
ASTI
$34.5M
| $11.4K | ﹤0.01% |
2
+1
| +100% | +$16.9K |
|
13387
PUT
Evogene
EVGN
$7.65M
| $11.4K | ﹤0.01% |
1,810
-220
| -11% | -$1.64K |
|
|
CHRN
13388
CALL
ChronoScale Holdings
CHRN
$2.82B
| $11.4K | ﹤0.01% |
460
+413
| +879% | +$9.76K |
|
13389
PUT
Farmers National Banc Corp
FMNB
$931M
| $11.4K | ﹤0.01% |
900
+400
| +80% | +$5.53K |
|
13390
PUT
TMC The Metals Company
TMC
$1.92B
| $11.3K | ﹤0.01% |
13,600
-49,300
| -78% | -$45.8K |
|
13391
CALL
First Financial Corp
THFF
$962M
| $11.2K | ﹤0.01% |
+300
| New | +$12.9K |
|
13392
CALL
Holley
HLLY
$382M
| $11.2K | ﹤0.01% |
4,100
+3,800
| +1,267% | +$9.71K |
|
|
AUUD
13393
Auddia
AUUD
$7.08M
| $11.2K | ﹤0.01% |
5
| – | – |
|
|
NSLR
13394
PUT
Neostellar Capital Corp
NSLR
$273M
| $11.2K | ﹤0.01% |
3,100
-56,542
| -95% | -$217K |
|
13395
PUT
System1
SST
$17.8M
| $11.2K | ﹤0.01% |
260
-8,360
| -97% | -$371K |
|
13396
CALL
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $11.2K | ﹤0.01% |
700
-1,400
| -67% | -$24.2K |
|
13397
PUT
Hanmi Financial
HAFC
$939M
| $11.1K | ﹤0.01% |
600
| – | – |
|
|
ISUN
13398
CALL
DELISTED
iSun, Inc. Common Stock
ISUN
| $11.1K | ﹤0.01% |
10,800
-4,800
| -31% | -$7.16K |
|
13399
REX American Resources
REX
$1.43B
| $11.1K | ﹤0.01% |
778
-57,696
| -99% | -$912K |
|
13400
CALL
Neuronetics
STIM
$151M
| $11.1K | ﹤0.01% |
3,800
-2,600
| -41% | -$13.1K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.